Modification of Hospitalization Risk by Gender and Dementia Status Between the Ages of 85 and 95 in a German Cohort Based on Health Claims Data. [PDF]
Doblhammer G, Rakuša E, Fink A.
europepmc +1 more source
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
Development of a Prediction Model for Community-Dwelling Older Adults at Risk of Long-Term Care with Dementia. [PDF]
Kazawa K +3 more
europepmc +1 more source
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley +1 more source
Treatment and prognosis of proximal humerus fracture in older adults: a retrospective cohort study using health insurance claims database. [PDF]
Saitsu A +12 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Factors associated with discharge to skilled nursing despite a clinical recommendation for inpatient rehabilitation. [PDF]
McCartney KM +7 more
europepmc +1 more source
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
Long-Term Survival and Life-Sustaining Device Use in Survivors of First and Second Out-of-Hospital Cardiac Arrest: Retrospective Cohort Study. [PDF]
Lin CH, Fan CY, Huang EP, Sung CW.
europepmc +1 more source

